How does participation in cureVision 2025 work?

Your participation in cureVision 2025 is structured as an equity investment. You become a shareholder in cureVision 2025 - similar to investing on the stock market, but in the pre-IPO phase. No subordinated loans, no reward-based crowdfunding campaigns, no pre-orders. In the event of success, you participate proportionally in the exit (company sale or IPO) or via dividend distributions. Example: Companisten who invested in BigRep participated in its listing on the Frankfurt Stock Exchange on July 31, 2024 (ticker B1GR). The minimum investment in cureVision 2025 is €10,000 in the Business Angel Club (for direct investments in the form of shares or GmbH equity interests) or €250 for private investors via a pooling vehicle. Each investment offering includes a legally required Securities Information Sheet (WIB), Key Information Document (BIB), or consumer information with mandatory risk disclosures.

What is the minimum investment in cureVision 2025?

The minimum investment in cureVision 2025 is €10,000 in the Companisto Angel Club for a direct investment (limited liability company shares or stock) or €250 for private investors via a pooling vehicle. There is no maximum investment amount per investment.

When do I receive a return from cureVision 2025?

A return from your cureVision 2025 investment arises at exit (trade sale or IPO) or through dividend distributions - as a shareholder you participate directly in the company’s value. The timing of an exit is not guaranteed; typical holding periods for startup investments range between 5 and 10 years. Examples from the Companisto portfolio: BigRep - listing on the Frankfurt Stock Exchange on July 31, 2024 (ticker B1GR). HERO - €40 million Series B in 2024 with Eight Roads and Federated Hermes. DiaMonTech - €8 million co-investment with Samsung Next in 2025 (largest EU equity crowdfunding round 2025). KoRo 6x return for Companisten upon sale in 2022. Through the Companisto secondary market, you can sell your cureVision 2025 shares to other Companisto investors before exit. Total loss of capital is possible.

Where can I find the Investment Information Sheet (Vermögensanlagen-Informationsblatt, VIB)?

The Securities Information Sheet (WIB) or Key Information Document (BIB) for cureVision 2025 can be found directly on this investment detail page as a link at the bottom of the page (below “Latest Companisten”). A central overview of all WIBs is available at companisto.com/wib and BIBs at companisto.com/bib. The information sheets contain the legally required risk disclosures and must be read in full before making any investment.

Where can I find the Securities Information Sheet (WIB) or the Key Information Document (KID)?

The Securities Information Sheet (WIB) or Key Information Document (BIB) for cureVision 2025 can be found directly on this investment detail page as a link at the bottom of the page (below “Latest Companisten”). A central overview of all WIBs is available at companisto.com/wib and BIBs at companisto.com/bib. The information sheets contain the legally required risk disclosures and must be read in full before making any investment.

Invest in startups from as little as € 250 with the new minimum investment amount.

Simple - digital - fast.

Funding Round Closed

Invest in cureVision 2025

This investment opportunity is now closed. Sign up to follow cureVision 2025 and be informed about future investment opportunities.

Invest in CUREVISION 2025

Award-winning MedTech start-up with CE-certified technology for fully automated wound analysis.

€ 2,319,114

Invested

717

Investors

Funding Goal

€ 2,342,500

Minimum investment

€ 250

Company Valuation

€ 11,700,000

Mediator

Companisto Wertpapier GmbH

Co-Investors

Angels4Health Business Angels, founding team, technology investor & Merk MIC GmbH

FINANCED

€ 2,319,114

Current investment opportunities

royos

Lieboch, AT

Pioneer in innovative joining technologies: Patented polymer stir-welding technology bonds plastic to metal, wood, or other...

We are close to funding goal!

€ 300,750

€ 350,000

Co-financing

Adaptive Balancing Power 2026

Pfungstadt, DE

High-Power Energy Storage at the Scaling Point: Patented, Over 42,000 Operating Hours in the Field, €1.6 Million in Order...

We are close to funding goal!

€ 4,162,300

€ 4,200,000

Co-financing

PLACED

Berlin, DE

Fast-growing B2B SaaS startup with EUR 180,000 ARR as of January 2026, over EUR 1 million in the pipeline, and an...

We are close to funding goal!

€ 1,092,500

€ 1,200,000

Co-financing

Points2BIM

Chemnitz, DE

AI platform for the digitization of existing buildings – 500,000 m² already captured and validated by leading...

€ 319,250

€ 450,000

Co-financing

Preventicus

Jena, DE

Clinically validated, 23 health insurers, over €2 million in revenue – now scaling through self-pay patients, partners,...

We are close to funding goal!

€ 1,286,900

€ 1,300,000

PlayAI

Munich, DE

Tech startup creating digital AI twins of professional athletes, with former Nasdaq C-level executives and professional...

We are close to funding goal!

€ 341,500

€ 370,000

Co-financing

pakajo 2026

Hamburg, DE

Global, AI-powered shipping platform with strong operational growth and revenue of EUR 3.1 million, already nearing...

Financing round ends in:

€ 1,254,950

€ 1,300,000

AMERIA AG – AI Made in Germany

Heidelberg, DE

SONY, SAMSUNG, and major U.S. tech companies are counting on AMERIA. AI Made in Germany – a leading German deep tech...

Financing round ends in:

€ 11,876,000

€ 11,950,000

Co-financing

GrOwnValve

Berlin, DE

Lifelong cure for heart valve defects. EU funded medtech startup devel-ops growing implants made from the patient’s own...

We are close to funding goal!

€ 3,085,603

€ 3,100,000

Summary

More Startups

Please note

The acquisition of the offered securities and investments is associated with considerable risks and can lead to the complete loss of the invested assets. The expected yield is not guaranteed and may be lower. Whether it is a security or an asset investment can be seen in the description of the investment opportunity.

If you have any questions about investing on Companisto, please contact our service team:

Toll-free phone number for investors calling from Germany:
0800 - 100 267 0

Companisto investors hotline:
+49(0)30 - 346 491 493

We are available Monday through Friday between 9 a.m. – 5 p.m.

For investors

Why invest? FAQ for Investors Angel Club Investments Information Sheets Securities Information Sheets Key Information Documents

Companisto

About us Media Info Career Netiquette Payment Details Partner Program ECCL Study 2025

For investors

Why invest? FAQ for Investors Angel Club Investments Information Sheets Securities Information Sheets Key Information Documents

Companisto

About us Media Info Career Netiquette Payment Details Partner Program ECCL Study 2025

Download our app

The Companisto app makes it even easier for you to invest.

Or scan the QR code with your phone camera

Download our app

The Companisto app makes it even easier for you to invest.

Or scan the QR code with your phone camera

We are rated 4.3 out of 5

For companies

Apply for financing Investment Model FAQ for Startups

We are rated 4.3 out of 5